Creatine fails to augment the benefits from resistance training in patients with HIV infection: A randomized, double-blind, placebo-controlled study

PLoS ONE

Volumn 4, Issue 2, 2009, Pages

  Sakkas, Giorgos K ^a,b,c   Mulligan, Kathleen ^a,b   DaSilva, Makani ^b   Doyle, Julie W ^d   Khatami, Hootan ^b   Schleich, Thomas ^e   Kent Braun, Jane A ^f   Schambelan, Morris ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF THESSALY   (Greece)

^d NORTHERN CALIFORNIA INSTITUTE FOR RESEARCH AND EDUCATION   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; CREATINE; CREATININE; INSULIN; PLACEBO; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY COMPOSITION; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG HYPERSENSITIVITY; DRUG SAFETY; DUAL ENERGY X RAY ABSORPTIOMETRY; ENERGY TRANSFER; FATIGUE; FEMALE; HOMEOSTASIS MODEL ASSESSMENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEAN BODY WEIGHT; LOADING DRUG DOSE; MAINTENANCE DRUG DOSE; MALE; MUSCLE STRENGTH; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RESISTANCE TRAINING; SUPPLEMENTATION; THERAPY EFFECT; TREATMENT DURATION; UNITED STATES;

EID: 84864278920     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0004605     Document Type: Article

References (54)

1. Grinspoon S, Mulligan K (2003) Weight loss and wasting in patients infected with human immunodeficiency virus. Clin Infect Dis 36: S69-78.
2. Shevitz AH, Wilson IB, McDermott AY, Spiegelman D, Skinner SC, et al. (2005) A comparison of the clinical and cost-effectiveness of 3 intervention strategies for AIDS wasting. J Acquir Immune Defic Syndr 38: 399-406.
3. Grinspoon S, Corcoran C, Parlman K, Costello M, Rosenthal D, et al. (2000) Effects of testosterone and progressive resistance training in eugonadal men with AIDS wasting. A randomized, controlled trial. Ann Intern Med 133: 348-355.
4. Rigsby LW, Dishman RK, Jackson AW, Maclean GS, Raven PB (1992) Effects of exercise training on men seropositive for the human immunodeficiency virus-1. Med Sci Sports Exerc 24: 6-12.
5. Lox CL, McAuley E, Tucker RS (1996) Aerobic and resistance exercise training effects on body composition, muscular strength, and cardiovascular fitness in an HIV-1 population. Int J Behav Med 3: 55-69.
6. Bhasin S, Storer TW (2000) Exercise regimens for men with HIV. Jama 284: 175-176.
7. Yarasheski KE, Tebas P, Stanerson B, Claxton S, Marin D, et al. (2001) Resistance exercise training reduces hypertriglyceridemia in HIV-infected men treated with antiviral therapy. J Appl Physiol 90: 133-138.
8. Roubenoff R, Wilson IB (2001) Effect of resistance training on self-reported physical functioning in HIV infection. Med Sci Sports Exerc 33: 1811-1817.
9. Robinson FP, Quinn LT, Rimmer JH (2007) Effects of high-intensity endurance and resistance exercise on HIV metabolic abnormalities: a pilot study. Biol Res Nurs 8: 177-185.
10. Dolan SE, Frontera W, Librizzi J, Ljungquist K, Juan S, et al. (2006) Effects of a supervised home-based aerobic and progressive resistance training regimen in women infected with human immunodeficiency virus: a randomized trial. Arch Intern Med 166: 1225-1231.
11. Smith DA, Perry PJ (1992) The efficacy of ergogenic agents in athletic competition. Part I: Androgenic-anabolic steroids. Ann Pharmacother 26: 520-528.
12. Smith DA, Perry PJ (1992) The efficacy of ergogenic agents in athletic competition. Part II: Other performance-enhancing agents. Ann Pharmacother 26: 653-659.
13. Nissen SL, Sharp RL (2003) Effect of dietary supplements on lean mass and strength gains with resistance exercise: a meta-analysis. J Appl Physiol 94: 651-659.
14. Mujika I, Padilla S (1997) Creatine supplementation as an ergogenic aid for sports performance in highly trained athletes: a critical review. Int J Sports Med 18: 491-496.
15. Kilduff LP, Vidakovic P, Cooney G, Twycross-Lewis R, Amuna P, et al. (2002) Effects of creatine on isometric bench-press performance in resistance-trained humans. Med Sci Sports Exerc 34: 1176-1183.
16. Gilliam JD, Hohzorn C, Martin D, Trimble MH (2000) Effect of oral creatine supplementation on isokinetic torque production. Med Sci Sports Exerc 32: 993-996.
17. Izquierdo M, Ibanez J, Gonzalez-Badillo JJ, Gorostiaga EM (2002) Effects of creatine supplementation on muscle power, endurance, and sprint performance. Med Sci Sports Exerc 34: 332-343.
18. Culpepper RM (1998) Creatine supplementation: safe as steak? South Med J 91: 890-892.
19. Snow RJ, McKenna MJ, Selig SE, Kemp J, Stathis CG, et al. (1998) Effect of creatine supplementation on sprint exercise performance and muscle metabolism. J Appl Physiol 84: 1667-1673.
20. Kinugasa R, Akima H, Ota A, Ohta A, Sugiura K, et al. (2004) Short-term creatine supplementation does not improve muscle activation or sprint performance in humans. Eur J Appl Physiol 91: 230-237.
21. Syrotuik DG, Bell GJ (2004) Acute creatine monohydrate supplementation: a descriptive physiological profile of responders vs. nonresponders. J Strength Cond Res 18: 610-617.
22. Green AL, Hultman E, Macdonald IA, Sewell DA, Greenhaff PL (1996) Carbohydrate ingestion augments skeletal muscle creatine accumulation during creatine supplementation in humans. Am J Physiol 271: E821-826.
23. Hubal MJ, Gordish-Dressman H, Thompson PD, Price TB, Hoffman EP, et al. (2005) Variability in muscle size and strength gain after unilateral resistance training. Med Sci Sports Exerc 37: 964-972.
24. Kent-Braun JA, Ng AV (2000) Skeletal muscle oxidative capacity in young and older women and men. J Appl Physiol 89: 1072-1078.
25. Kent-Braun JA, Ng AV, Doyle JW, Towse TF (2002) Human skeletal muscle responses vary with age and gender during fatigue due to incremental isometric exercise. J Appl Physiol 93: 1813-1823.
26. Karatzaferi C, Giakas G, Ball D (1999) Fatigue profile: a numerical method to examine fatigue in cycle ergometry. Eur J Appl Physiol Occup Physiol 80: 508-510.
27. Mazess RB, Barden HS, Bisek JP, Hanson J (1990) Dual-energy x-ray absorptiometry for total-body and regional bone-mineral and soft-tissue composition. Am J Clin Nutr 51: 1106-1112.
28. Lo JC, Mulligan K, Tai VW, Algren H, Schambelan M (1998) "Buffalo hump" in men with HIV-1 infection. Lancet 351: 867-870.
29. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419.
30. Hespel P, Op't Eijnde B, Van Leemputte M, Urso B, Greenhaff PL, et al. (2001) Oral creatine supplementation facilitates the rehabilitation of disuse atrophy and alters the expression of muscle myogenic factors in humans. J Physiol 536: 625-633.
31. Volek JS, Ratamess NA, Rubin MR, Gomez AL, French DN, et al. (2004) The effects of creatine supplementation on muscular performance and body composition responses to short-term resistance training overreaching. Eur J Appl Physiol 91: 628-637.
32. Volek JS, Kraemer WJ, Bush JA, Boetes M, Incledon T, et al. (1997) Creatine supplementation enhances muscular performance during high-intensity resistance exercise. J Am Diet Assoc 97: 765-770.
33. Smith SA, Montain SJ, Matott RP, Zientara GP, Jolesz FA, et al. (1999) Effects of creatine supplementation on the energy cost of muscle contraction: a 31PMRS study. J Appl Physiol 87: 116-123.
34. Greenhaff PL, Bodin K, Soderlund K, Hultman E (1994) Effect of oral creatine supplementation on skeletal muscle phosphocreatine resynthesis. Am J Physiol 266: E725-730.
35. Earnest CP, Snell PG, Rodriguez R, Almada AL, Mitchell TL (1995) The effect of creatine monohydrate ingestion on anaerobic power indices, muscular strength and body composition. Acta Physiol Scand 153: 207-209.
36. Kreider RB, Ferreira M, Wilson M, Grindstaff P, Plisk S, et al. (1998) Effects of creatine supplementation on body composition, strength, and sprint performance. Med Sci Sports Exerc 30: 73-82.
37. Komura K, Hobbiebrunken E, Wilichowski EK, Hanefeld FA (2003) Effectiveness of creatine monohydrate in mitochondrial encephalomyopathies. Pediatr Neurol 28: 53-58.
38. Tarnopolsky MA, Roy BD, MacDonald JR (1997) A randomized, controlled trial of creatine monohydrate in patients with mitochondrial cytopathies. Muscle Nerve 20: 1502-1509.
39. Gordon A, Hultman E, Kaijser L, Kristjansson S, Rolf CJ, et al. (1995) Creatine supplementation in chronic heart failure increases skeletal muscle creatine phosphate and muscle performance. Cardiovasc Res 30: 413-418.
40. Tarnopolsky MA, Mahoney DJ, Vajsar J, Rodriguez C, Doherty TJ, et al. (2004) Creatine monohydrate enhances strength and body composition in Duchenne muscular dystrophy. Neurology 62: 1771-1777.
41. Walter MC, Lochmuller H, Reilich P, Klopstock T, Huber R, et al. (2000) Creatine monohydrate in muscular dystrophies: A double-blind, placebocontrolled clinical study. Neurology 54: 1848-1850.
42. Tarnopolsky M, Zimmer A, Paikin J, Safdar A, Aboud A, et al. (2007) Creatine monohydrate and conjugated linoleic acid improve strength and body composition following resistance exercise in older adults. PLoS ONE 2: e991.
43. Tarnopolsky M, Mahoney D, Thompson T, Naylor H, Doherty TJ (2004) Creatine monohydrate supplementation does not increase muscle strength, lean body mass, or muscle phosphocreatine in patients with myotonic dystrophy type 1. Muscle Nerve 29: 51-58.
44. Kornblum C, Schroder R, Muller K, Vorgerd M, Eggers J, et al. (2005) Creatine has no beneficial effect on skeletal muscle energy metabolism in patients with single mitochondrial DNA deletions: a placebo-controlled, double-blind 31PMRS crossover study. Eur J Neurol 12: 300-309.
45. Walter MC, Reilich P, Lochmuller H, Kohnen R, Schlotter B, et al. (2002) Creatine monohydrate in myotonic dystrophy: a double-blind, placebocontrolled clinical study. J Neurol 249: 1717-1722.
46. Zange J, Kornblum C, Muller K, Kurtscheid S, Heck H, et al. (2002) Creatine supplementation results in elevated phosphocreatine/adenosine triphosphate (ATP) ratios in the calf muscle of athletes but not in patients with myopathies. Ann Neurol 52: 126; author reply 126-127.
47. Rawson ES, Clarkson PM, Price TB, Miles MP (2002) Differential response of muscle phosphocreatine to creatine supplementation in young and old subjects. Acta Physiol Scand 174: 57-65.
48. Derave W, Marescau B, Vanden Eede E, Eijnde BO, De Deyn PP, et al. (2004) Plasma guanidino compounds are altered by oral creatine supplementation in healthy humans. J Appl Physiol 97: 852-857.
49. Murata H, Hruz PW, Mueckler M (2000) The mechanism of insulin resistance caused by HIV protease inhibitor therapy. J Biol Chem 275: 20251-20254.
50. Nolte LA, Yarasheski KE, Kawanaka K, Fisher J, Le N, et al. (2001) The HIV protease inhibitor indinavir decreases insulin-and contraction-stimulated glucose transport in skeletal muscle. Diabetes 50: 1397-1401.
51. Sinnwell TM, Sivakumar K, Soueidan S, Jay C, Frank JA, et al. (1995) Metabolic abnormalities in skeletal muscle of patients receiving zidovudine therapy observed by 31P in vivo magnetic resonance spectroscopy. J Clin Invest 96: 126-131.
52. Balsom PD, Soderlund K, Ekblom B (1994) Creatine in humans with special reference to creatine supplementation. Sports Med 18: 268-280.
53. Grinspoon S, Carr A (2005) Cardiovascular risk and body-fat abnormalities in HIV-infected adults. N Engl J Med 352: 48-62.
54. Szczech LA, Gupta SK, Habash R, Guasch A, Kalayjian R, et al. (2004) The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection. Kidney Int 66: 1145-1152.